Related Experiment Video
Updated: Jul 4, 2026

10:22
Comprehensive Spatial Profiling of Species-agnostic Transcriptomes via Stereo-seq
Published on: October 31, 2025
Spatial transcriptomics in ovarian biology technologies: computational challenges, and biological insights
Ruixu Huang1, Brittany Anne Goods2
1Thayer School of Engineering, Dartmouth College, Hanover, NH, United States.
Summary
Spatially resolved transcriptomics (ST) reveals gene expression in intact ovarian tissue, complementing single-cell RNA sequencing. This review details ST platforms and their applications in ovarian research, highlighting integration strategies for deeper insights.
Area of Science:
- Reproductive biology and genomics.
- Biotechnology and bioinformatics.
Background:
- The ovary's complex cellular interactions are crucial for its function.
- Dissociation-based methods like single-cell RNA sequencing (scRNA-seq) lose vital spatial context.
- Spatially resolved transcriptomics (ST) preserves tissue architecture for gene expression analysis.
Purpose of the Study:
- To provide a comprehensive review of Spatially resolved transcriptomics (ST) platforms.
- To assess the suitability of ST technologies for ovarian research.
- To discuss computational challenges and multi-modal integration strategies in ovarian ST studies.
Main Methods:
- Review of major ST platforms: sequencing-based (Visium, Visium HD, Stereo-seq, GeoMx) and imaging-based (Xenium, MERSCOPE, CosMx).
- Survey of 40 published studies applying ST to ovarian biology (atlases, aging, follicle development, cancer).
- Discussion of computational analyses and multi-modal integration (e.g., with scRNA-seq, spatial proteomics).
Main Results:
- ST platforms offer distinct technical features, resolution, and suitability for ovarian research.
- ST applications span ovarian atlases, aging, follicle dynamics, and cancer studies.
- Multi-modal integration enhances the resolution of ovarian molecular complexity.
Conclusions:
- No single ST platform is optimal for all ovarian research questions.
- Careful selection of ST platforms based on biological goals and tissue scale is critical.
- Advancing ST in ovarian research requires aligning platform capabilities with research objectives for mechanistic discovery.
